Kyoto, Japan

Shinya Oishi

USPTO Granted Patents = 4 


Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2004-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Shinya Oishi: Innovator in Pharmaceutical Research

Introduction

Shinya Oishi is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific diseases. With a total of 4 patents to his name, Oishi's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among his latest patents, Oishi has developed a TGF-β signal transduction inhibitor. This invention provides a compound represented by a specific formula, which is useful for the prophylaxis or treatment of TGF-β-related diseases. Another notable patent is a metastin derivative, which is characterized by its superior blood stability and its ability to suppress cancer metastasis and growth. This compound is also represented by a defined formula and can be used in pharmaceutical compositions.

Career Highlights

Oishi has worked with esteemed institutions such as Kyoto University and Takeda Pharmaceutical Company Limited. His research has focused on innovative solutions to complex medical challenges, showcasing his dedication to advancing healthcare through scientific discovery.

Collaborations

Some of his notable coworkers include Nobutaka Fujii and Kenji Tomita. Their collaborative efforts have contributed to the success of various research projects and innovations in the pharmaceutical field.

Conclusion

Shinya Oishi's contributions to pharmaceutical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…